QUOTE AND NEWS
FierceBiotech  Jan 26  Comment 
Amgen just lost a key regulatory race. Armed with a handy FDA shortcut voucher, Regeneron and its Big Pharma partner Sanofi announced today that the agency has accepted their application for the powerful new PCSK9 cholesterol drug alirocumab and...
Forbes  Jan 26  Comment 
Early on Monday Sanofi and Regeneron leapfrogged their rival Amgen to gain leadership in the race to bring a new class of cholesterol drugs to market. The new development could potentially give Sanofi and Regeneron a month on the market by...
FiercePharma  Jan 22  Comment 
Sanofi may not have its next CEO figured out yet, but it's worked out what it's going to pay departed helmsman Chris Viehbacher. The former chief exec will take home €2.96 million in severance following his abrupt dismissal last fall, plus...
Clusterstock  Jan 22  Comment 
By Astrid Wendlandt and Andrew Callus PARIS (Reuters) - European pharmaceuticals group Sanofi on Thursday said it had agreed to pay 4.44 million euros ($5.06 million) in total to ousted chief executive Chris Viehbacher. Viehbacher, who left in...
FiercePharma  Jan 22  Comment 
Another purported Sanofi CEO candidate has publicly knocked himself off the list. Takeda chief operating officer and CEO-in-waiting Christophe Weber says he's not interested in the job. That makes two top pharma execs who've rebuffed the French...
FiercePharma  Jan 21  Comment 
Law firms are hoping to find plaintiffs for shareholder lawsuits against Sanofi. Potential claims focus on an alleged illegal kickback strategy for the company's diabetes franchise, designed to boost sales.
Market Intelligence Center  Jan 21  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Sanofi-Aventis (SNY) that includes 4.39% downside protection. Sell one contract of the Mar. '15...
Market Intelligence Center  Jan 20  Comment 
After Friday’s trading in Sanofi-Aventis (SNY) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 3.58% or 22.15% (for comparison purposes only), while providing 4.21% downside...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki